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Peptidoglycan is a giant molecule that forms the cell wall that surrounds
bacterial cells. It is composed of alternating N-acetylglucosamine (NAG) and
N-acetylmuramic acid (NAM) residues connected by -(1,4)-glycosidic bonds
and cross-linked with short polypeptide chains. Owing to the increasing
antibiotic resistance against drugs targeting peptidoglycan synthesis, studies of
enzymes involved in the degradation of peptidoglycan, such as N-acetylglucos-
aminidases, may expose new, valuable drug targets. The scientific challenge
addressed here is how lysozymes, muramidases which are likely to be the most
studied enzymes ever, and bacterial N-acetylglucosaminidases discriminate
between two glycosidic bonds that are different in sequence yet chemically
equivalent in the same NAG-NAM polymers. In spite of more than fifty years of
structural studies of lysozyme, it is still not known how the enzyme selects the
bond to be cleaved. Using macromolecular crystallography, chemical synthesis
and molecular modelling, this study explains how these two groups of enzymes
based on an equivalent structural core exhibit a difference in selectivity. The
crystal structures of Staphylococcus aureus N-acetylglucosaminidase autolysin E
(AtlE) alone and in complex with fragments of peptidoglycan revealed that
N-acetylglucosaminidases and muramidases approach the substrate at alternate
glycosidic bond positions from opposite sides. The recognition pocket for NAM
residues in the active site of N-acetylglucosaminidases may make them a
suitable drug target.
1. Introduction
Peptidoglycan (PG) is a living structure that builds the
bacterial cell wall. Bacterial growth, division, colonization and
biofilm formation rely heavily on the ability of cells to remodel
their wall, which includes both the degradation and synthesis
of PG. Staphylococci represent a large group of bacteria that
live on humans and can cause severe infections in immuno-
compromised people (Lowy, 1998; Varrone et al., 2011;
Vincent et al., 2009). The widespread use of antibiotics in
recent decades has resulted in the emergence of antibiotic-
resistant and multiple antibiotic-resistant strains such as
-lactam-antibiotic (penicillin) resistant [extended-spectrum
-lactamase (ESBL)-producing] bacteria, methicillin-resistant
Staphylococcus aureus (S. aureus) (MRSA) and vancomycin-
resistant S. aureus (VRSA) (Archer, 1998; Dantes et al., 2013;
Gardete & Tomasz, 2014; Hanberger et al., 2011; Hiramatsu et
al., 1997; Nunes et al., 2007; Xia et al., 2013; Zetola et al., 2005).
Therefore, it is important to explore alternative targets for the
treatment of bacterial infections.
Alternating N-acetylglucosamine (NAG) and N-acetyl-
muramic acid (NAM) residues connected by -(1,4)-glycosidic
bonds and cross-linked with short polypeptide chains
assemble the PG (Vocadlo et al., 2001). Two groups of
enzymes, muramidases and N-acetylglucosaminidases, cleave
alternate but chemically equivalent glycosidic bonds in the
NAG-NAM polymers.
Lysozyme, a muramidase, is the first line of immune defence
against bacteria. It was the first enzyme and the second protein
for which a crystal structure was determined at atomic reso-
lution (Blake et al., 1965; Johnson, 1998) and is likely to be the
most studied enzyme ever. Research to date has addressed its
folding, evolution and catalytic mechanism (Anderson et al.,
1981; Kuroki et al., 1993; Matthews, 1996; Matthews et al., 1981;
Vocadlo et al., 2001); however, insight into the mechanism of
the selectivity of its binding of NAG-NAM polymers has
remained unexplored. We still do not know how lysozymes
differ from N-acetylglucosaminidases in terms of recognition
of the scissile bond. Yet, the substrate selectivity among
hydrolases of different kinds and species is the foundation of
the differences in their biological roles.
The S. aureus Mu50 genome (an MRSA strain with
vancomycin-intermediate resistance; VISA) encodes five
N-acetylglucosaminidases belonging to glycoside hydrolase
family 73 (GH73 family). Four of them, SAV2307, SAV1052,
SAV1775 and SAV2644 [also named AtlE (SagA, LytD),
AtlA, SagB and ScaH, respectively; SAVxxxx identifiers are
according to entries in the http://www.genome.jp database],
are widely distributed throughout the genomes of S. aureus
strains and are critical for cell enlargement. It has been shown
that S. aureus lacking all five N-acetylglucosaminidases is not
viable, which implies that they are essential for cell viability
(Wheeler et al., 2015). The best studied among them is
SAV1052, the major bifunctional autolysin (AtlA; Biswas et
al., 2006; Heilmann et al., 1997; Oshida et al., 1995; Sugai et al.,
1995).
The amidase activity of AtlA was confirmed and analyzed
by structural studies of homologous enzymes from S. epider-
midis (Zoll et al., 2010) and later S. aureus (Bu¨ttner et al.,
2014). However, the other N-acetylglucosaminidases from
S. aureus remained unexplored. The crystal structure of AtlE
and its complexes with substrate fragments described here
provide insight into the mechanism of NAG-NAM binding,
whereas a comparison with structural data for lysozymes and
their complexes with substrate fragments enabled us to seek
out the structural differences responsible for docking of the
two alternate glycosidic bonds in the NAG-NAM polymer.
2. Methods
2.1. Cloning, protein production and purification
AtlE is a 258-amino-acid protein encoded by the SAV2307
gene in the S. aureus Mu50 genome, while AtlA is a 1248-
amino-acid protein encoded by the SAV1052 gene from the
same genome (Fig. 1). The truncated sequences of the glucos-
aminidase domain of AtlE (SAV2307 residues 35–258;
UniProt code A0A0H3JT72) and the glucosaminidase domain
of AtlA (Glu-AtlA; SAV1052 residues 1012–1231; UniProt
code Q931U5) were used. The nucleotide sequences were
amplified from the genomic DNA of S. aureus Mu50 using
KOD Hot Start Polymerase and were cloned into the
pMCSG7 plasmid in frame with an N-terminal His tag as
described by Eschenfeldt et al. (2009). The mutants were
prepared by the overlap extension method (Ho et al., 1989).
The genes were expressed in the Escherichia coli (E. coli)
BL21 (DE3) expression strain grown in ZYM5052 auto-
induction medium (Studier, 2005). To facilitate production of
the protein in a soluble form, the cells were initially grown at
37C. When the optical density measured at 600 nm (OD600)
reached 1, the cells were transferred to 25C and left for 16 h.
Selenomethionine minimal medium (SeMetMM) was
prepared as described by Guerrero et al. (2001). A culture of
the E. coli BL21 (DE3) pMCSG7-AtlE transformants was
grown overnight in 20 ml LB medium supplemented with
ampicillin (100 mg ml1) at 37Cwith shaking at 250 rev min1.
The next day, this cell suspension was used as an inoculum for
1 l of the same medium and the OD600 was monitored until it
reached 1. The cell culture was then centrifuged for 15 min
at 4000 rev min1 and the pellet was resuspended in 1 l
SeMetMM with a final concentration of 1 mM IPTG and
incubated at 18C and 250 rev min1 for an additional 20 h.
The cells were pelleted by centrifugation (15 min at 7000g),
resuspended in buffer A (0.03M Tris pH 7.5, 0.4M NaCl)
supplemented with 1 mg ml1 lysozyme, and frozen and
disrupted by freeze–thaw cycles and sonication. The proteins
were purified from the cell lysate on an A¨KTAxpress FPLC
system (GE Healthcare) using a two-step purification
protocol. The first purification step was Ni2+-affinity chroma-
tography on a HiTrap IMAC FF column (GE Healthcare)
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Figure 1
Domain organization of S. aureus autolysins AtlA and AtlE. Proteins are marked with the protein and the gene name. Only theN-acetylglucosaminidase
domains were used in this study.
equilibrated in buffer A with 10 mM imidazole. The bound
proteins were eluted with buffer A containing 300 mM
imidazole and applied onto a HiPrep 26/60 Sephacryl S200
size-exclusion column (GE Healthcare) equilibrated in buffer
A. The fractions containing the pure protein were collected,
concentrated, desalted against 20 mM HEPES pH 7.5,
100 mM NaCl and stored at 20C.
2.2. Biochemical analysis of AtlE and Glu-AtlA activities
AtlE and Glu-AtlA were tested against the S. aureus cell
wall (Odintsov et al., 2004) and two synthetic substrates:
the (NAM-NAG)2
red tetrasaccharide (Fig. 2) and (NAG)6
red.
Analysis of the degradation products was performed by mass
spectrometry.
The tetrasaccharide (NAM-NAG)2 was purified by HPLC
using Micrococcus lysodeikticus peptidoglycan fragments
solubilized by digestion with Enterococcus faecalis autolysin
A. (NAG)6 was purchased from Dextra Laboratories.
2.3. NAG-NAM disaccharide synthesis
The NAG-NAM disaccharide {2-acetamido-4-O-(2-acet-
amido-2-deoxy--d-glucopyranosyl)-3-O-[(R)-1-carboxyethyl]-
2-deoxy--d-glucopyranose} was prepared according the
protocol introduced by Kantoci et al. (1987) and papers cited
therein, with some revisions (Fig. 3). Selective opening of the
4,6-benzylidene ring of benzyl 2-acetamido-4,6-O-benzyli-
dene-3-O-[(R)-1-(methoxycarbonyl)ethyl]-2-deoxy--d-gluco-
pyranoside (1) to give benzyl 2-acetamido-6-O-benzyl-3-O-
[(R)-1-(methoxycarbonyl)ethyl]-2-deoxy--d-glucopyranoside
(2) was performed with iodine and triethylsilane instead of
sodium cyanoborohydride as previously described (Keglevic
et al., 1985). Glycosidic bond formation between activated
glucosamine 3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido--d-
glucopyranosyl chloride (3) and selectively protected muramic
acid 2 in the presence of silver trifluoromethanesulfonate in
extremely dry conditions gave 2-acetamido-4-O-(3,4,6-tri-O-
acetyl-2-deoxy-2-phthalimido--d-glucopyranosyl)-6-O-benzyl-
2-deoxy-3-O-[(R)-1-methoxycarbonyl)ethyl]--d-glucopyrano-
side (4). Removal of the phthalimido group from compound 4
with hydrazine followed by acetylation gave benzyl 2-acet-
amido-4-O-(2-acetamido-3,4,6-tri-O-acetyl-2-deoxy--d-gluco-
pyranosyl)-6-O-benzyl-2-deoxy-3-O-[(R)-1-(methoxycarbonyl)-
ethyl]--d-glucopyranoside (5). Saponification of the acetyl
and methyl groups and removal of the benzyl groups with
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Figure 2
Analysis of AtlE and Glu-AtlA digestion products of (NAM-NAG)2
red substrate. (a) Schematic representation of the tetrasaccharide substrate with the
expected digestion products. (b, c) Mass-spectrometric analysis of the digestion products of (b) AtlE and (c) Glu-AtlA. The expected molecular peaks
are annotated. The same amount of substrate/digestion products was analysed in both cases.
catalytic hydrogenation gave NAG-NAM (Kantoci et al., 1987;
Keglevic et al., 1985).
2.3.1. Benzyl 2-acetamido-6-O-benzyl-3-O-[(R)-1-
(methoxycarbonyl)ethyl]-2-deoxy-a-D-glucopyranoside (2).
Compound 1 (630 mg; 1.3 mmol) was dissolved in dry
dichloromethane (DCM; 10 ml), and iodine (370 mg) and
Et3SiH (3.7 ml) were added. The reaction was stirred in an ice
bath, and after 30 min and 1 h additional iodine (37 mg) and
Et3SiH (370 ml) were added. The reaction was terminated
after 2 h, diluted with DCM (40 ml) and washed first with
NaHCO3 (20 ml) and then with water (20 ml). The organic
layers were dried with Na2SO4, evaporated and chromato-
graphed on a silica-gel column in 3:2 DCM:acetone and 9:1
DCM:methanol (MeOH) solvent systems. Crystallization from
acetone:diisopropyl ether gave compound 2 (330 mg; 52%).
Electrospray ionization mass spectrometry (ESI-MS):
C26H33NO8, 488.4 [M+H]
+; calculated, 488.5. Rf = 0.65 (9:1
DCM:MeOH).
2.3.2. Benzyl 2-acetamido-4-O-(3,4,6-tri-O-acetyl-2-
deoxy-2-phthalimido-b-D-glucopyranosyl)-6-O-benzyl-2-deoxy
3-O-[(R)-1-(methoxycarbonyl)ethyl]-a-D-glucopyranoside (4).
The glucosyl chloride 3 (280 mg; 0.62 mmol) and protected
muramic acid 2 (100 mg; 0.21 mmol) with silver trifluoro-
methanesulfonate (AgTf; 210 mg; 0.82 mmol) as a catalyst
were subjected to Anderson’s apparatus for glycosidic
coupling (Nashed & Anderson, 1982) followed by molecular
sieving. Dry DCM (2 ml) was added and the reaction was
stirred overnight under nitrogen at room temperature. After
this, chloroform was added to the suspension and it was
centrifuged. The residue was washed twice with chloroform.
The chloroform supernatants were washed with a saturated
aqueous solution of NaHCO3 and then with water, and then
dried over Na2SO4. The solvent was evaporated and the
product was purified by flash silica-gel column chromato-
graphy in 8:4:1 diethyl ether:petroleum ether:isopropanol
(iPrOH) and 9:1 DCM:MeOH solvent systems. After the
second column, compound 4 (62 mg; 33%) was obtained.
ESI-MS: C46H53N2O17, 905.4 [M+H]
+; calculated, 905.3;
C46H52N2NaO17, 927.4 [M+Na]
+; calculated, 927.3. Rf = 0.54
(8:4:1 diethyl ether:petroleum ether:isopropanol).
2.3.3. Benzyl 2-acetamido-4-O-(2-acetamido-3,4,6-tri-O-
acetyl-2-deoxy-b-D-glucopyranosyl)-6-O-benzyl-2-deoxy-3-O-
[(R)-1-(methoxycarbonyl)ethyl]-a-D-glucopyranoside (5).
Disaccharide 4 (45 mg; 0.0498 mmol) was dissolved in dry
MeOH (1.376 ml) with 0.1M NaOMe/MeOH (145 ml). The
reaction was stirred at room temperature for 1 h, after which
additional 0.1M NaOMe/MeOH (145 ml) was added and
stirring was continued for 15 min. The reaction solution was
neutralized with Amberlite IR-120 (H+), filtered and evapo-
rated. The residue was dissolved in 96% ethanol (2.25 ml) and
hydrazine hydrate (16.88 ml). The reaction was stirred for 2 h
under reflux (80C). The reaction mixture was evaporated
after the addition of toluene. The residue was dissolved in 1:1
pyridine:acetic anhydride (1.2 ml) and stirred overnight. After
this, the solvent was evaporated after the addition of toluene,
and the residue was purified by flash silica-gel column chro-
matography in 2:3:1 ethyl acetate (EtOAc):iPrOH:petroleum
ether to give compound 5 (27 mg; 67%).
ESI-MS: C40H52N2NaO16, 839.3 [M+Na]
+; calculated, 839.3.
Rf = 0.50 (2:3:1 EtOAc:iPrOH:petroleum ether).
2.3.4. 2-Acetamido-4-O-(2-acetamido-2-deoxy-b-D-gluco-
pyranosyl)-3-O-[(R)-1-carboxyethyl]-2-deoxy-a-D-glucopyran-
ose (NAG-NAM). Compound 5 (35 mg; 0.043 mmol) was
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Figure 3
Synthesis of the NAG-NAM disaccharide. Reagents and conditions: (a)
Et3SiH, I2, 0
C, 2 h; (b) AgTf, RT, 18 h; (c) NaOMe, MeOH, RT, 1 h;
hydrazine hydrate, EtOH, 80C, 2 h; pyridine, acetic anhydride, RT, 18 h;
(d) 0.5M KOH, dioxane, RT, 48 h; H2, Pd/C, EtOH:HOAc:water; RT,
18 h.
dissolved in dioxane (1.75 ml) and 0.5M KOH (0.875 ml) was
added to adjust the pH to 12. The reaction was stirred at room
temperature for 48 h and then neutralized by Amberlite IR-
120 (H+), filtered and evaporated. The residue was dissolved
in 6:1.5:1.5 EtOH:acetic acid (HOAc):water (5.25 ml), and
Pd/C (10%; 46 mg) was added. The reaction was hydrogenated
at room temperature overnight. After this, the reaction was
filtered over a small column of Celite to remove the catalyst,
and the filtrate was evaporated. The residue was crystallized
from 1:10 MeOH:ether to give NAG-NAM (15 mg; 70%).
ESI-MS: C19H32N2NaO13, 519.2 [M+Na]
+; calculated, 519.2.
Rf = 0.55 (1:1:1:1 n-butanol:HOAc:EtOAc:water).
2.4. Protein crystallization and structure determination
Crystals of AtlE (concentrated to 15 mg ml1 in 20 mM
HEPES pH 7.5, 100 mM NaCl) were grown in 2M NaCl, 2M
ammonium sulfate using the vapour-diffusion method. The
crystallization drop consisted of 1 ml protein solution and 1 ml
crystallization buffer. The crystals were cryoprotected by
soaking in the crystallization buffer containing 30% glycerol.
Data were collected from native and SeMet-derivative crystals
on the XRD beamline at the Elettra synchrotron, Trieste, Italy.
The native structure was solved with the help of an SeMet
derivative using data collected at the remote wavelength,
exploiting the anomalous signal from seven SeMet residues
using the HKL-3000 software (Minor et al., 2006). The native
structure was rebuilt and refined usingMAIN (Turk, 2013) and
REFMAC (Murshudov et al., 2011), and was deposited in the
PDB (Berman et al., 2000) with accession code 4pia.
2.5. Determination of the crystal structures of peptidoglycan-
fragment complexes
The NAG-NAM disaccharide was synthesized as described
and muramyl dipeptide (MDP) was purchased from Invi-
trogen. Complexes with AtlE with NAG-NAM andMDP were
obtained by soaking native crystals with a 10 mM solution of
the ligands. Data from crystals of the native protein
complexed with MDP and of the E138A mutant complexed
with NAG-NAM were collected at a wavelength of 0.9184 A˚
on beamline 14.1 at the BESSY synchrotron, Berlin, Germany,
whereas the diffraction data for the native enzyme complexed
with NAG-NAM were collected at an in-house X-ray source
using a copper rotating anode (Bruker). The diffraction data
were integrated with HKL-2000 (Otwinowski & Minor, 1997).
The structures were built with MAIN (Turk, 2013) using the
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Table 1
Data-collection and refinement statistics for AtlE.
Structure SeMet Native NAG-NAM complex
E138A mutant,
NAG-NAM complex MDP complex
PDB code 4pia 4pia 4pi7 4pi8 4pi9
Crystal parameters
Resolution range (A˚) 34.1–1.40 (1.41–1.40) 23.00–1.47 (1.52–1.47) 50.00–1.60 (1.69–1.60) 38.40–1.39 (1.44–1.39) 38.75–1.48 (1.53–1.48)
Space group P212121 P212121 P212121 P212121 P212121
Unit-cell parameters
a (A˚) 46.37 46.60 46.31 46.011 45.63
b (A˚) 69.75 69.93 69.78 69.72 69.31
c (A˚) 73.28 73.27 73.58 73.54 73.42
 =  =  () 90 90 90 90 90
Data collection
Beamline Elettra XRD Elettra XRD Bruker Proteum BESSY 14.1 BESSY 14.1
Wavelength (A˚) 0.9786 1.0000 1.5410 0.9184 0.9184
Total reflections 405310 229540 222199 312334 251936
Unique reflections 46877 (1940) 41472 (3953) 31914 (2985) 48332 (4753) 39606 (3756)
Multiplicity 8.6 (4.2) 5.5 (3.7) 3.7 (1.9) 6.5 (6.5) 6.4 (6.5)
Completeness (%) 98.3 (82.7) 99.30 (95.97) 99.45 (94.82) 99.92 (99.69) 99.55 (96.26)
Mean I/(I) 15.4 (1.0) 39.2 (4.3) 24.24 (3.34) 26.91 (3.00) 20.16 (2.07)
Wilson B factor (A˚2) 11.72 16.14 15.96 19.66
Rmerge 0.113 (0.884) 0.043 (0.259) 0.121 (0.234) 0.034 (0.593) 0.045 (0.746)
Refinement statistics
Rwork 0.1492 0.1563 0.152 0.1772
Rfree 0.1715 0.1868 0.1755 0.208
No. of non-H atoms
Total 2111 2116 2146 2111
Macromolecules 1844 1826 1837 1832
Ligands 9 50 53 42
Water 258 240 256 237
Protein residues 225 223 222 223
R.m.s.d., bonds (A˚) 0.017 0.015 0.018 0.015
R.m.s.d., angles () 1.81 1.64 1.9 1.7
Ramachandran favoured (%) 97 97 97 98
Clashscore 2.45 3.24 2.94 2.45
Average B factors (A˚2)
Overall 16.6 21.7 23.2 29.5
Macromolecules 14.9 20.2 21.7 27.9
Ligands 22.1 22.5 21.4 39.0
Solvent 28.2 33.4 34.4 40.1
topology library and geometric restraints provided by PURY
(Andrejasˇicˇ et al., 2008) and finally refined with REFMAC
(Murshudov et al., 2011) for deposition. The geometry of the
binding of the disaccharide was equivalent in the two crystal
structures; therefore, only the complex with the native
sequence is shown in the figures. However, all three crystal
structures were deposited in the PDB with accession codes
4pi7, 4pi8 and 4pi9. For data and refinement statistics, see
Table 1.
2.6. Similarity to other structures
The DALI server (Holm & Rosenstro¨m, 2010) was used to
identify glucosaminidase enzymes belonging to the GH73
family in the CAZy database (Lombard et al., 2014) with
similar structures to the determined structure of AtlE. The
identified proteins were analyzed by structure-based sequence
alignment performed by STRAP (Gille & Fro¨mmel, 2001).
2.7. Superimposition of substrate fragments on the AtlE
complexes
To compare the binding of the NAG-NAM disaccharide and
MPD in the light of the structures of the other related
complexes, we superimposed both AtlE complexes with the
crystal structures of NAG3 bound to goose-type lysozyme
from Atlantic cod (ACOD; Helland et al., 2009; PDB entry
3gxr) as the closest related lysozyme,
NAG-NAM-peptide bound to T4 lyso-
zyme (T4_L; Kuroki et al., 1993; PDB
entry 148l), NAG3 bound to goose
lysozyme (GLYZ; Weaver et al., 1995;
PDB entry 154l) and NAM-NAG-NAM
in complex with chicken lysozyme
(CLYZ; Kelly et al., 1979; PDB entry
9lyz) (see Fig. 7c).
2.8. Molecular modelling of NAG-NAM
substrates into the active sites of AtlE
and ACOD
The (NAG)6 was built first. The
model was built by filling the gap
between the (NAG)2 and (NAG)3 parts
of the ACOD structure (Helland et al.,
2009; PDB entry 3gxr) with the missing
NAG residue. The resulting hexa-
saccharide was energetically minimized
by restraining the matching saccharide
residues to the crystal structures of the
ACOD complex using MAIN (Turk,
2013). To build a model that matches
the muramidase/lysozyme substrate, the
corresponding NAG residues were
substituted with NAM residues. The
resulting (NAG-NAM)3 hexasaccharide
was energetically minimized again.
To build the substrate model corre-
sponding to N-acetylglucosaminidase
activity, the structures of AtlE and
ACOD were superimposed using
FATCAT (Ye & Godzik, 2003). Using
superimposition parameters, the
(NAG)6 model was transferred from
the ACOD environment to the AtlE
structure. Then, similarly as for lyso-
zyme, the corresponding alternate NAG
residues were substituted with NAM
residues. The resulting (NAG-NAM)3
model was slightly shifted to match the
position of the NAG-NAM disaccharide
in the complex with AtlE, and was
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Figure 4
Structure of AtlE. The fold of the structure in the core and lobe regions is shown. The compact
-helical structural core forms the lower part of both domains, whereas the R- and L-lobes
containing short -helical and -strand regions reside on top of the R- and L-domains, respectively.
Between the lobes, there is a long groove that runs across the entire central part of the molecule.
The secondary-structure elements in the figures are numbered in the order that they occur in the
sequence. The core of the structure consists of six helices of different lengths: 5, 6, 7 and 12
from the L-domain and 13 and 14 from the R-domain. In contrast, each lobe contains two short
-helices and two -hairpins. In the L-lobe the -hairpin precedes the two -helices, whereas in the
R-lobe the -hairpin is positioned between them (1 and 4). (a) Sequence of AtlE. The grey text
indicates the part excluded from expression. The regions corresponding to the secondary-structure
elements are shown in the same colour code as used in (b). (b) Fold of AtlE. The four conserved
helices in the core region are coloured blue, whereas the other two core region helices are shown in
cyan. The secondary-structure elements belonging to the L- and R-lobes are shown in green and
yellow, respectively.
energetically minimized by constraining
the positions of the atoms of the 3, 2
residues to the positions observed in the
crystal structure.
3. Results
3.1. Biochemical activity
Both proteins, AtlE and Glu-AtlA,
were active against the cell-wall
substrate, and they both only cleaved
the NAG--(1,4)-NAM glycosidic bond,
which corresponds to N-acetylglucos-
aminidase activity, whereas (NAG)6 was
not cleaved. The cleavage of the (NAM-
NAG)2
red tetrasaccharide producing the
NAM-NAG and NAM-NAGred di-
saccharides indicates N-acetylglucos-
aminidase activity, whereas NAMred and
NAG-NAM-NAGred products would
indicate muramidase activity. Only
NAM-NAGred, with a molecular weight
of 499.21 Da, was found in both cases
(Fig. 2).
3.2. Structure
AtlE is well defined along the whole
chain apart from the first three residues,
which were built as alanines, and His79
and Lys80, which were disordered and
therefore were not built (Fig. 4a).
Several side chains were built with
alternative conformations and a few
side chains were disordered. Helix 10
has higher B values, most likely indi-
cating statistical disorder of this surface
feature. The AtlE crystal structure
(Table 1) shows a heart-shaped globular
fold composed of separate left (L) and
right (R) domains (Fig. 4b). To address
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Figure 5
Structural similarity of AtlE. AtlE and the
related structures of LytB SP (PDB entry
4q2w), Lmo (PDB entry 3fi7), FlgJ (PDB entry
2zyc), ACOD (PDB entry 3gxk) and HLYZ
(PDB entry 1iwt) are presented from top to
bottom. The left column shows the chain trace
with the secondary-structure elements in the
same orientation. The right column presents
the architecture of the folds schematically.
Helices are shown as cylinders and -strands
as arrows. The colour codes are the same as
those used in Fig. 4. Red circles mark the
position of the catalytic glutamic acid. Three-
dimensional images of folds were prepared
with PyMOL (DeLano, 2002) and MAIN
(Turk, 2013) and were rendered with Raster3D
(Merritt & Bacon, 1997).
the structural parts, we further divided the structure into core
and lobe regions. The compact -helical structural core forms
the lower part of both domains, whereas the R-lobe and L-
lobe contain short -helical and -strand regions, respectively.
Between the lobes, there is a long groove that runs across the
entire central part of the molecule. The structure has addi-
tional five amino acids (SNAAA) at the N-terminus remaining
after cleavage of the His tag by TEV protease. The secondary-
structure assignment of the AtlE structure (Figs. 4 and 5) is
used as the reference in comparisons with other structures.
3.3. Similarity to other structures
Using the crystal structure of AtlE, the DALI server
identified several glucosaminidase enzymes with similar
structures belonging to the GH73 family in the CAZy data-
base (Lombard et al., 2014): Streptococcus pneumoniae LytB
(LytB SP; PDB entry 4q2w; Z-score = 16.9; Bai et al., 2014),
Listeria monocytogenes Lmo1076 (Lmo; PDB entry 3fi7;
Z-score = 8.0; Bublitz et al., 2009) and Sphingomonas sp. A1
FlgJ (PDB entry 2zyc; Z-score = 7.3; Hashimoto et al., 2009). A
significant structural homology was also found with the G-type
lysozyme from Atlantic cod (ACOD; PDB entry 3gxr; Z-score
= 6.7; Helland et al., 2009) belonging to the GH23 family.
Owing to the similarity in architecture, although not spotted
by the DALI server, we also included the human lysozyme
structure (HLYZ; PDB entry: 1iwt) in the comparison as a
representative of the goose-type lysozymes (Joti et al., 2002).
The alignment of the six enzymes in Figs. 5 and 6 reflects their
structural similarity, but also points out their diversity. This is
also reflected in the rather large root-mean-square deviation
(r.m.s.d.) of superimposed structures, which is in the range
from 1.9 to 5.0 A˚ (Table 2). The structure-based alignment of
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Figure 6
Structure-based sequence alignment of AtlE, LytB SP, ACOD, Lmo, FlgJ and HLYZ (the proteins from Fig. 5). Alignment was performed with STRAP
(Gille & Fro¨mmel, 2001). The regions at the N-termini, which do not exhibit any similarity among the structures, were excluded from this alignment.
Hyphens correspond to deletions, whereas dots, lowercase and uppercase characters correspond to residues that are identical, similar and different,
respectively, from the sequence at the top. The catalytic Glu residue and the residues addressed in the text for their importance in substrate binding are
marked with asterisks.
Table 2
Superimposition of structures.
Structures from the GH73 family and selected lysozymes were superimposed
by 3D_CE (Shindyalov & Bourne, 1998) as a whole and in the region of the
four conserved helices. The values for the latter are shown in parentheses. The
columns indicate the structures, their PDB codes, their whole chain lengths,
their superimposed residues, the r.m.s.d.s of their deviations and the identities
of the residues in the superimposed regions.
Structure
PDB
code
Chain
length
Superimposed
residues
R.m.s.d.
(A˚)
Chain identity
(%)
LytB SP 4q2w 263 139 (61) 1.9 (1.1) 36 (38)
Lmo 3fi7 177 115 (53) 2.9 (1.3) 23 (21)
FlgJ 2zyc 156 118 (41) 3.2 (3.1) 25 (24)
ACOD 3gxk 185 124 (59) 4.7 (1.4) 9 (7)
HLYZ 1iwt 130 115 (33) 5.0 (2.2) 10 (9)
GLYZ 154l 185 122 (55) 3.7 (1.5) 10 (11)
T4_L 148l 162 96 (33) 4.7 (2.5) 5 (12)
CLYZ 9lyz 129 102 (23) 4.4 (3.5) 8 (4)
all sequences (Fig. 6) by STRAP (Gille & Fro¨mmel, 2001)
revealed that the proteins share only a single identical residue,
Glu138 in AtlE (shown in red), mutation of which to Ala
rendered AtlE inactive, whereas the mutation of other acidic
residues in the vicinity (Glu145, Asp167 and Asp227, which
are 14, 11 and 8 A˚ away from the carboxylic O atoms of
Glu138) exposed no additional residues assisting in catalysis.
This latter indicated that the mechanism of catalysis is
different from that observed in lysozymes (Vocadlo et al.,
2001). It merits mention that the alignment of the AtlE and
LytB SP sequences starts at residues Asn82 and Asn130,
respectively. The alignment of AtlE with the Lmo, FlgJ,
ACOD and HLYZ sequences starts at AtlE residue Gly106
and the Gln78, A153, Ala42 and Lys1 residues of Lmo, FlgJ,
ACOD and HLYZ, respectively. This indicates their large
structural diversity in their N-terminal region corresponding
to the R-lobe of AtlE.
All six helices comprising the core of AtlE (Figs. 4 and 5)
are similar to the C-terminal domain of LytB SP, which the
authors called the GH73 domain. The conservation of helices
6, 7, 12 and 14 shown in dark blue is typical for proteins
that adopt the lysozyme-like fold. These helices form the
central core of the AtlE structure and
have counterparts in Lmo, FlgJ, HLYZ
and ACOD (Fig. 5). The exceptions are
the HLYZ structure, in which the
C-terminal helix is broken into two
parts (6) and extended, and the 5
helix from the ACOD structure, which
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Figure 7
Complexes of AtlE with NAG-NAM and MDP.
The AtlE structure is presented with a
transparent surface, which makes the regions
and residues in contact with the ligands visible.
The averaged kick Fobs  Fcalc electron-density
map (Prazˇnikar et al., 2009) contoured at 0.8
and 1.2 around the ligands is shown for (a)
MDP and (b) the disaccharide NAG-NAM,
respectively. The ligand residues and AtlE
residues in contact with the ligands are marked,
and their side chains are drawn in stick
representation. The colours cyan, yellow and
green indicates that the binding sites are built
from three chain regions. TheN-acetyl group of
NAM is positioned equivalently in both
complexes. Hydrogen bonds (grey dashed
lines) pin NAM to the main-chain atoms of
the Gly164 NH group and the Tyr224 carbonyl,
while the O atoms of the lactyl moieties form a
hydrogen bond to the OH group of the Tyr201
side chain. (a) The alanine hydrophobic side
chain of MDP is positioned within the hydro-
phobic environment formed by the side chains
of Ile163, Gly164 and Phe196, whereas the
d-Glu residue is disordered and points into the
solvent, while (b) the N-acetyl group of the
NAG residue forms a hydrogen bond to the
main-chain NH group of Gln223. (c) Compar-
ison of similar ligands superimposed on the
AtlE structure. AtlE is shown as a transparent
white surface with the catalytic Glu138 side
chain labelled. The crystal structures of the
muramyl dipeptide and the NAG-NAM disac-
charide determined in complex with AtlE are
shown as stick models in red and orange,
respectively. They are labelled MDP and
disaccharide. The muramyl dipeptide ligand
bound to T4 lysozyme (T4_L; PDB entry 148l)
is shown in green and labelled T4-muropeptide.
The disaccharide and trisaccharide structures
determined in complex with ACOD (PDB
entry 3gxr) are shown in blue and labelled
ACOD NAG. This figure was prepared with
MAIN (Turk, 2013) and rendered with
Raster3D (Merritt & Bacon, 1997).
is curved, extended and wrapped along the inter-domain
interface, from which the chain folds back and around the
C-terminal helix and contacts the L-domain from below. The
four-helical cores (three-helical in the cases of HLYZ and
GLYZ) of the compared structures superimpose on the AtlE
core with smaller r.m.s.d.s (1.1–3.5 A˚) than the whole struc-
tures (Table 2), yet the similarity between the structures of
lysozymes and AtlE is more at the level of the folding pattern
than at the level of the structural details of amino-acid resi-
dues, apart from the catalytic Glu138.
The L-core is built similarly from -helical elements in all
compared structures (Fig. 5), whereas the R-cores differ in size
and structure. The three helices from the L-core of AtlE
shown in blue are present in all compared structures, whereas
the AtlE 5 helix, shown in cyan, is present only in LytB SP. In
the R-core, the AtlE C-terminal helix (14), shown in blue, is
present in all structures except HLYZ.
In AtlE and ACOD the R-core is built
from the N-terminal and C-terminal
parts of the chain, whereas in the
HLYZ, Lmo and FlgJ structures the R-
core is folded entirely from the
C-terminal part of the chain.
The R-lobe is unique to the AtlE
structure and is absent in all others. It is
built from the N-terminal parts of the
sequence. In the LytB SP structure the
GH73 domain does not have an R-lobe;
its space is, however, occupied by the
N-terminal domain. The L-lobes are
present in all listed structures. They are
mainly built from elements of -struc-
ture, yet they differ in folding pattern
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Figure 8
Structural differences between N-acetylglucos-
aminidases and muramidases (lysozymes) in
binding glycan cell-wall components. Images of
three-dimensional models were prepared with
MAIN (Turk, 2013) and rendered with
Raster3D (Merritt & Bacon, 1997). (a) and
(c) show a schematic representation of the
approach of N-acetylglucosaminidases (a) and
muramidases (c) to the poly-NAG-NAM
saccharide, where the lactyl moieties are
oriented towards the L- and R-lobes, which
correspond to glucosaminidase and muramid-
ase binding, respectively. (b) and (d) are
models of the hexasaccharide (NAG-NAM)3
bound to the AtlE and ACOD active sites,
shown in ball-and-stick representation against
the surface of the targeted enzyme. The atom
colour codes of the hexasaccharide model are
blue and red for N and O atoms, respectively. C
atoms are coloured orange, except for those
from the lactyl group, which indicate the site of
peptide-chain attachment; these are coloured
green. The surface is white, except for the part
corresponding to the carboxylic group of the
catalytic residue Glu138, which is coloured red.
The chain trace of ACOD is shown in blue
against the surface of AtlE (b), whereas the
chain trace of AtlE is shown in cyan against the
surface of ACOD (d). (e) Cleavage sites of
muramidases and N-acetylglucosaminidases.
The three-dimensional model of the NAG-
NAM-NAG-NAM tetrasaccharide is shown in
ball-and-stick representation using the same
colour codes as in (b) and (d). The cleavage
sites of muramidases and N-acetylglucosamini-
dases are marked with arrows.
and in their positioning. Only the HLYZ structure contains a
three-stranded -sheet, whereas in the Lmo and FlgJ struc-
tures there are long -hairpins. -Hairpins are also found in
the AtlE structure. AtlE and LytB SP have an -helix (AtlE
has two) in this region.
Hence, the core regions share the four-helix core of the
lysozyme fold; however, the L- and R-lobe regions responsible
for substrate binding have little in common not only when
comparing (mostly still putative) N-acetylglucosaminidases
with lysozymes, but also among the structures and sequences
of GH73 family members themselves (Figs. 5 and 6).
3.4. Substrate binding
To experimentally gain insight into the substrate-binding
mechanism, we determined crystal structures of AtlE in
complex with MDP (Fig. 7a) and the NAG-NAM disaccharide
(Fig. 7b) synthesized as described in Fig. 3.
In the MDP complex the NAM and alanine residues are
unambiguously resolved by the electron-density map, whereas
the positioning of the atoms of the d-glutamic acid residue is
less defined, as indicated by the electron-density map. The
N-acetyl group of NAM is pinned to the surface of AtlE by
hydrogen bonds to the main-chain atoms of the Gly164 NH
group and the Tyr224 carbonyl (Fig. 7a). The O atom of the
lactyl moiety of the NAM residue forms a hydrogen bond to
the OH group of the Tyr201 side chain. The alanine hydro-
phobic side chain is positioned within the hydrophobic
environment formed by the side chains of Ile163, Gly164 and
Phe196, whereas the d-glutamic acid residue is disordered and
points into the solvent.
NAG-NAM is the smallest repeating unit of the glycan part
of the peptidoglycan cell wall. In the complex of AtlE with
NAG-NAM we observed that only a single molecule of the
disaccharide was bound to the AtlE active site (Fig. 7b). As
the closest atom to the catalytic residue Glu138, the O1 atom
of the NAM residue is positioned 6.7 A˚ away from the OE2
atom of the carboxylic group. The disaccharide is positioned
above the Gln221–Ser226 loop shown in green. It is pinned to
the surface at the bottom of the cleft by four hydrogen bonds:
three formed by the NAM residue and one by NAG. The
NAM moiety binds to the AtlE structure equivalently to that
observed in the MDP–AtlE complex (Fig. 7a). The N-acetyl
group of the NAG residue forms a hydrogen bond to the main-
chain NH group of Gln223. The N-acetyl group of NAM is
pinned to the surface of AtlE by hydrogen bonds to the main-
chain atoms of the Gly164 NH group and the Tyr224 carbonyl.
The O atom of the lactyl moiety of the NAM residue forms a
hydrogen bond to the OH group of the Tyr201 side chain.
Numerous solvent molecules, two chloride ions and a sulfate
ion are positioned in the region around the disaccharide.
To complement these structural data, we searched the PDB
(Protein Data Bank; Berman et al., 2000) for entries
containing NAM residues (AMU according to the PDB
nomenclature) and found several structures of NAM in
complex with a hydrolase active site related to peptidoglycan
substrate recognition. The structures were complexes of a
NAM-peptide intermediate with T4 phage lysozyme (T4_L;
PDB entry 148l; Kuroki et al., 1993) and NAM-NAG-NAM in
complex with chicken lysozyme (CLYZ; PDB entry 9lyz; Kelly
et al., 1979). Because the structural homology search showed
similarity to the goose-type lysozyme from Atlantic cod
(ACOD; PDB entry 3gxr; Helland et al., 2009), we also
included its complexes with NAG trimers. These ligand
structures are shown superimposed on the AtlE structure in
Fig. 7(c). The superimposed structures show similar posi-
tioning of the carbohydrate rings, yet different positions and
orientations of the peptidyl extensions (the T4 muropeptide in
green is pointing to the right and the AtlE-bound muropep-
tide MDP in red is pointing to the left), which provide insight
into the difference in specificity between N-acetylglucos-
aminidases and muramidases.
The five resolved NAG carbohydrate rings from the ACOD
structure (PDB entry 3gxr; Helland et al., 2009) fit into the
active site of AtlE. A similar position is also occupied by
NAG3 in complex with goose lysozyme (GLYZ; PDB entry
154l; Weaver et al., 1995) and chicken lysozyme (CLYZ; PDB
entry 9lyz; Kelly et al., 1979). However, they are not shown in
the figure because they overlap with the NAGs from the
ACOD structure. Taken together, these structures show that
carbohydrate rings are similarly positioned in all of these
structures. They also reveal the positions of the subsites from
3 to +3 using the nomenclature proposed by Davies et al.
(1997) or the B to G nomenclature as applied in the ACOD
structural paper (Helland et al., 2009). According to the
Davies nomenclature, the observed NAM residues in the AtlE
complexes (Figs. 7a and 7b) bind to the 2 sugar-binding
subsite and NAG binds at the 3 subsite.
4. Discussion
Using the gathered structural data, we addressed the substrate
selectivity of the enzymes. We used the structures of the
complexes shown in Fig. 7(c) as templates to generate models
of hexasaccharides with an alternating NAG-NAM sequence
in the structures of the active-site clefts of AtlE and ACOD as
representative enzymes for the N-acetylglucosaminidase and
muramidase activities, respectively. Fig. 8 shows a three-
dimensional and schematic comparison of the bound substrate
models. The chain trace of AtlE is shown on a background of
the ACOD surface (Fig. 8d) and vice versa (Fig. 8b), while the
substrate models correspond to the structures represented by
surfaces. Figs. 8(a) and 8(b) and Figs. 8(c) and 8(d) demon-
strate the differences between the shape of the active-site
clefts and the way that the hexasaccharide substrates bind into
them. Because the NAG and NAM residues are in alternating
positions, the lactyl moieties shown in green are on the
opposite sides of the active site in the AtlE (Fig. 8a) and
ACOD models (Fig. 8c).
The opposite positioning of the lactyl moieties in the active
sites of the N-acetylglucosaminidase AtlE and the muramid-
ase ACOD predicts that features on the left side of the active-
site cleft of AtlE are responsible for the recognition of lactyl
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moieties and peptides from the glycopeptides, whereas the
features on the right side of the active-site cleft of AtlE should
prevent the binding of lactyl moieties and peptides attached to
them. The reverse is true for ACOD substrate binding.
Indeed, Figs. 8(a) and 8(b) show that in the L-lobe and above
the 2 and +1 positions of the lactyl moieties of NAM resi-
dues bound to the AtlE surface, there is sufficient space to
accommodate the peptidyl extensions. However, in the ACOD
structure there are features (shown in blue) protruding
outside the AtlE surface that can prevent the binding of
peptidyl extensions attached at these two positions. In accor-
dance with Figs. 8(c) and 8(d), the reverse is true for the
ACOD-bound substrate model. The AtlE hairpin region from
Gly52 to Asn68 (shown in cyan) positioned at the top of the R-
lobe of the AtlE structure (Fig. 8d) forms the wall of the active
site on the right and thereby prevents the binding of peptidyl
extensions attached to the lactyl group of NAM residues,
whereas the ACOD surface (Fig. 8d) provides sufficient space
to accommodate peptides bound to the lactyl groups of NAM
residues. It should be mentioned that chicken-type lysozyme
structures provide even fewer restraints than the goose type.
This analysis demonstrates that the lobe regions in both types
of enzymes indeed contain structural features that are
responsible for the acceptance and rejection of the peptidyl
moiety of the glycopeptide cell wall. Furthermore, the
comparison of the chain trace of the lysozyme structures
(ACOD, HLYZ and GLYZ), including the T4 phage lysozyme
(T4_L), and N-acetylglucosaminidase structures (LytB SP,
Lmo and FlgJ) superimposed on the AtlE structure in the
regions of the lactyl moieties of the N-acetylglucosaminidases
revealed two common and relevant differences for substrate
recognition. (i) The chains of lysozymes in the L-lobe region
after the catalytic Glu run directly across the NAM 1 moiety,
whereas in all compared N-acetylglucosaminidase structures
the chain after the catalytic site Glu folds to the left according
to the view in Fig. 5. As consequence, the lysozyme and N-
acetylglucosaminidase loops building the L-lobe are posi-
tioned alternatively. (ii) The NAM 2 lactyl moiety is absent
in chicken-type lysozyme structures (HLYZ, CLYZ and T4_L)
owing to a different positioning of 12 (using the AtlE
numbering). In goose-type lysozyme structures (GLYZ and
ACOD) an additional helix, the last turn of which (Tyr151–
Gly156 in ACOD) is followed by a loop, fills this space. These
differences indicate that the analysis of the binding of
substrate models to AtlE and ACOD is consistent with other
structural data. (This latter analysis is not presented in a figure
owing to the differences in the overlapping structural
components which obscure the view, as indicated by the
limited regions corresponding to equivalent parts and the
rather large r.m.s.d. of their superimposition parameters
shown in Table 2, and also by the low similarity at the
sequence level shown in Fig. 6.) Hereby, we have answered the
basic question as to how peptides attached to the peptido-
glycan cell-wall component direct the docking to bring the
desired glycosidic bond between the peptidyl NAM-NAG and
NAG-NAM to the catalytic sites of N-acetylglucosaminidases
and lysozyme-like muramidases.
As our data and biochemical analysis of lysozyme activities
(Vocadlo et al., 2001) showed, selectivity between the NAG-
NAM and NAM-NAG glycosidic bonds also exists at the level
of the saccharide (NAG-NAM)n and (NAG)n substrates with
no peptidyl extensions attached. In the substrate binding
corresponding to muramidase activity the lactyl group is
positioned in the 3, 1 and +2 subsites, whereas in the
substrate binding corresponding to the N-acetylglucos-
aminidase activity the lactyl group of N-acetylmuramic acid is
positioned in the 2, +1 and +3 subsites. Clearly, there is no
difference in the chemical environment of the glycosidic bonds
between the two combinations of the carbohydrate rings, yet
the muramidases cleave the glycosidic bond between the
NAM O4 and NAG C1 atoms, whereas the N-acetylglucos-
aminidases cleave the glycosidic bond between the NAG O4
and NAM C1 atoms. In addition, lysozymes/muramidases also
cleave the glycosidic bond between two consecutive NAG
residues, whereas we have shown here that AtlE and Glu-
AtlA cannot. Evidently, the difference between the NAM
residues and the NAG residues should come from recognition
of the lactyl group.
Therefore, we searched for the structural features that are
responsible for the acceptance and rejection of the lactyl
moieties of the NAM residues. In the lysozyme complexes, the
lactyl moiety is not stabilized by any interaction with the
underlying enzyme structure, whereas the N atom of the
amide link of alanine in phage lysozyme is oriented against the
main-chain carbonyl group of Gln105 (Anderson et al., 1981;
Helland et al., 2009; Kelly et al., 1979; Kuroki et al., 1993;
Weaver et al., 1995). This positioning indicates that lysozymes
select the side of NAG-NAM polymers by excluding the
approach of the lactyl moiety from the ‘wrong’ side, but do not
require it at the other side. It also explains why lysozymes can
also cleave NAG polymers. The AtlE–NAG-NAM complex
structure presented here, however, reveals that the lactate
group of the NAM 2 residue forms a hydrogen bond to
Tyr201 and leaves sufficient space behind it to accommodate
the peptidyl moiety (Figs. 7a and 7b). The recognition of the
NAM residue leads to a twist in the NAG-NAM chain at the
3 position. The absence of AtlE activity against NAG
substrates can be attributed to the extended but not twisted
conformation of the NAG substrate, which disables productive
binding at the 3 and 2 positions. This brief analysis indi-
cates that N-acetylglucosaminidases direct the binding of
polysaccharide NAG-NAM substrates by selective recognition
of the lactyl moiety specific to the murein structure, whereas
muramidases do not. This conclusion reveals an irony in the
nomenclature introduced in the early days of NAG-NAM
polysaccharide-degradation studies (Berger & Weiser, 1957),
predating the structural insight available now. If history could
be changed, this structural analysis would suggest that it may
be more appropriate to swap the terms referring to the
muramidase and N-acetylglucosaminidase activities, as only
the latter is based on muramyl residue selection and binding,
whereas the former does not require it.
Taken together, the analysis of structures of the AtlE and
lysozyme complexes and saccharides enabled us to expose
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specific structural features that exclude the binding of the
substrate molecules in an incompatible manner and thereby
explain the difference between the N-acetylglucosaminidase
and muramidase activities. To achieve this specificity, both
enzyme families adapted to their respective target in the
glycan substrate structure: the glycans linked with -glycosidic
bonds form extended structures with carbohydrate rings in the
chair conformation. As shown in the side view (Fig. 8e), the
chain exhibits a zigzag pattern. The odd number of bonds
(five) along the polysaccharide chain separating the two
consecutive glycosidic bond O atoms positions the O atoms in
alternating positions, where every other atom points either up
or down. If the N-acetylglucosaminidases recognized the
muramic moieties on the same side as the muramidases, then
the catalytic residue from the bottom would not be able to
reach the O atom of the glycosidic bond positioned at the top.
Such binding would require approach of the catalytic residue
from the top. To preserve the common catalytic residue
construct, the glycan chain must be approached from two
opposite sides and the substrate-selection mechanism is
adopted for each case. Evolution has endowed N-acetyl-
glucosaminidases with structural features that accept lactate
moieties on NAM residues on the L-side of the active-site
cleft, whereas muramidases achieve their specificity by not
allowing them to bind on the L-side. The absence of selective
recognition of the lactyl group on the R-side, however, enables
them to process NAG polymers as well. As exposed by our
structural analysis, this important difference in access to the
active-site cleft suggests that N-acetylglucosaminidases may
be suitable targets for novel antibiotic-discovery research. The
extent of structural differences in the lobe regions among the
N-acetylglucosaminidases, however, suggests that targeting of
various bacterial species may require the design of species-
specific drugs. If successful, such an approach may lead to
diminished ‘pollution’ of the biosphere by reducing the
harmful impact of the undesired spread of resistance against
antibiotics and maintaining the normal microbiome (Blaser,
2016).
Acknowledgements
Wladek Minor is gratefully acknowledged for adapting the
HKL software to support the PILATUS 2M detector and
for running the data through the HKL-3000 structure-
determination pipeline in 2010, which solved the SeMet
structure. We also acknowledge A. Usenik for careful reading
of and comments on the manuscript.
Funding information
Funding for this research was provided by: Slovenian
Research Agency (award Nos. P1-0048, IO-0005, IO-0048);
European Regional Development Fund (85%)/Slovenian
Ministry of Education, Science and Sport (15%) (development
of CIPKeBiP funding) (award No. OP13.1.1.2.02.0005);
Ministry of Science and Education of the Republic of Croatia
(award No. 098-0982933-2936); Biotechnology and Biological
Sciences Research Council (award No. BBSRC BB/N00095
1/1); Medical Research Council (award No. MR/N00267 9/1).
References
Anderson, W. F., Gru¨tter, M. G., Remington, S. J., Weaver, L. H. &
Matthews, B. W. (1981). J. Mol. Biol. 147, 523–543.
Andrejasˇicˇ, M., Prazˇnikar, J. & Turk, D. (2008). Acta Cryst. D64,
1093–1109.
Archer, G. L. (1998). Clin. Infect. Dis. 26, 1179–1181.
Bai, X.-H., Chen, H.-J., Jiang, Y.-L., Wen, Z., Huang, Y., Cheng, W.,
Li, Q., Qi, L., Zhang, J.-R., Chen, Y. & Zhou, C.-Z. (2014). J. Biol.
Chem. 289, 23403–23416.
Berger, L. R. & Weiser, R. S. (1957). Biochim. Biophys. Acta, 26,
517–521.
Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N.,
Weissig, H., Shindyalov, I. N. & Bourne, P. E. (2000). Nucleic Acids
Res. 28, 235–242.
Biswas, R., Voggu, L., Simon, U. K., Hentschel, P., Thumm, G. &Go¨tz,
F. (2006). FEMS Microbiol. Lett. 259, 260–268.
Blake, C. C. F., Koenig, D. F., Mair, G. A., North, A. C. T., Phillips,
D. C. & Sarma, V. R. (1965). Nature (London), 206, 757–761.
Blaser, M. J. (2016). Science, 352, 544–545.
Bublitz, M., Polle, L., Holland, C., Heinz, D. W., Nimtz, M. &
Schubert, W. D. (2009). Mol. Microbiol. 71, 1509–1522.
Bu¨ttner, F. M., Zoll, S., Nega, M., Go¨tz, F. & Stehle, T. (2014). J. Biol.
Chem. 289, 11083–11094.
Dantes, R., Mu, Y., Belflower, R., Aragon, D., Dumyati, G., Harrison,
L. H., Lessa, F. C., Lynfield, R., Nadle, J., Petit, S., Ray, S. M.,
Schaffner, W., Townes, J. & Fridkin, S. (2013). JAMA Int. Med. 173,
1970–1978.
Davies, G. J., Wilson, K. S. & Henrissat, B. (1997). Biochem. J. 321,
557–559.
DeLano, W. L. (2002). PyMOL. http://www.pymol.org.
Eschenfeldt, W. H., Lucy, S., Millard, C. S., Joachimiak, A. & Mark,
I. D. (2009). Methods Mol. Biol. 498, 105–115.
Gardete, S. & Tomasz, A. (2014). J. Clin. Invest. 124, 2836–2840.
Gille, C. & Fro¨mmel, C. (2001). Bioinformatics, 17, 377–378.
Guerrero, S. A., Hecht, H.-J., Hofmann, B., Biebl, H. & Singh, M.
(2001). Appl. Microbiol. Biotechnol. 56, 718–723.
Hanberger, H., Walther, S., Leone, M., Barie, P. S., Rello, J., Lipman,
J., Marshall, J. C., Anzueto, A., Sakr, Y., Pickkers, P., Felleiter, P.,
Engoren, M. & Vincent, J. L. (2011). Int. J. Antimicrob. Agents, 38,
331–335.
Hashimoto, W., Ochiai, A., Momma, K., Itoh, T., Mikami, B.,
Maruyama, Y. & Murata, K. (2009). Biochem. Biophys. Res.
Commun. 381, 16–21.
Heilmann, C., Hussain, M., Peters, G. & Go¨tz, F. (1997). Mol.
Microbiol. 24, 1013–1024.
Helland, R., Larsen, R. L., Finstad, S., Kyomuhendo, P. & Larsen,
A. N. (2009). Cell. Mol. Life Sci. 66, 2585–2598.
Hiramatsu, K., Hanaki, H., Ino, T., Yabuta, K., Oguri, T. & Tenover,
F. C. (1997). J. Antimicrob. Chemother. 40, 135–136.
Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K. & Pease, L. R.
(1989). Gene, 77, 51–59.
Holm, L. & Rosenstro¨m, P. (2010). Nucleic Acids Res. 38, W545–
W549.
Johnson, L. N. (1998). Nature Struct. Biol. 5, 942–944.
Joti, Y., Nakasako, M., Kidera, A. & Go, N. (2002). Acta Cryst. D58,
1421–1432.
Kantoci, D., Keglevic´, D. & Derome, A. E. (1987). Carbohydr. Res.
162, 227–235.
Keglevic, D., Pongracic, M. & Kantoci, D. (1985). Croat. Chem. Acta,
58, 569–581.
Kelly, J. A., Sielecki, A. R., Sykes, B. D., James, M. N. G. & Phillips,
D. C. (1979). Nature (London), 282, 875–878.
Kuroki, R., Weaver, L. H. & Matthews, B. W. (1993). Science, 262,
2030–2033.
research papers
IUCrJ (2017). 4, 185–198 M. Mihelicˇ et al.  Selection of cleavage sites in NAG-NAM polymers 197
Lombard, V., Golaconda Ramulu, H., Drula, E., Coutinho, P. M. &
Henrissat, B. (2014). Nucleic Acids Res. 42, D490–D495.
Lowy, F. D. (1998). N. Engl. J. Med. 339, 520–532.
Matthews, B. W. (1996). FASEB J. 10, 35–41.
Matthews, B. W., Gru¨tter, M. G., Anderson, W. F. & Remington, S. J.
(1981). Nature (London), 290, 334–335.
Merritt, E. A. & Bacon, D. J. (1997).Methods Enzymol. 277, 505–524.
Minor, W., Cymborowski, M., Otwinowski, Z. & Chruszcz, M. (2006).
Acta Cryst. D62, 859–866.
Murshudov, G. N., Skuba´k, P., Lebedev, A. A., Pannu, N. S., Steiner,
R. A., Nicholls, R. A., Winn, M. D., Long, F. & Vagin, A. A. (2011).
Acta Cryst. D67, 355–367.
Nashed, M. A. & Anderson, L. (1982). J. Am. Chem. Soc. 104, 7282–
7286.
Nunes, A. P., Schuenck, R. P., Bastos, C. C., Magnanini, M. M., Long,
J. B., Iorio, N. L. & dos Santos, K. R. N. (2007). Braz. J. Infect. Dis.
11, 345–350.
Odintsov, S. G., Sabala, I., Marcyjaniak, M. & Bochtler, M. (2004). J.
Mol. Biol. 335, 775–785.
Oshida, T., Sugai, M., Komatsuzawa, H., Hong, Y.-M., Suginaka, H. &
Tomasz, A. (1995). Proc. Natl Acad. Sci. USA, 92, 285–289.
Otwinowski, Z. & Minor, W. (1997). Methods Enzymol. 276, 307–
326.
Prazˇnikar, J., Afonine, P. V., Guncˇar, G., Adams, P. D. & Turk, D.
(2009). Acta Cryst. D65, 921–931.
Shindyalov, I. N. & Bourne, P. E. (1998). Protein Eng. 11, 739–747.
Studier, F. W. (2005). Protein Expr. Purif. 41, 207–234.
Sugai, M., Komatsuzawa, H., Akiyama, T., Hong, Y.-M., Oshida, T.,
Miyake, Y., Yamaguchi, T. & Suginaka, H. (1995). J. Bacteriol. 177,
1491–1496.
Turk, D. (2013). Acta Cryst. D69, 1342–1357.
Varrone, J. J., Li, D., Daiss, J. L. & Schwarz, E. M. (2011). Bonekey
Osteovision, 8, 187–194.
Vincent, J.-L., Rello, J., Marshall, J., Silva, E., Anzueto, A., Martin,
C. D., Moreno, R., Lipman, J., Gomersall, C., Sakr, Y. & Reinhart,
K. (2009). JAMA, 302, 2323–2329.
Vocadlo, D. J., Davies, G. J., Laine, R. & Withers, S. G. (2001). Nature
(London), 412, 835–838.
Weaver, L. H., Gru¨tter, M. G. & Matthews, B. W. (1995). J. Mol. Biol.
245, 54–68.
Wheeler, R., Turner, R. D., Bailey, R. G., Salamaga, B., Mesnage, S.,
Mohamad, S. A., Hayhurst, E. J., Horsburgh, M., Hobbs, J. K. &
Foster, S. J. (2015). Mbio, 6, e00660-15.
Xia, J., Gao, J., Kokudo, N., Hasegawa, K. & Tang, W. (2013). Biosci.
Trends, 7, 113–121.
Ye, Y. & Godzik, A. (2003). Bioinformatics, 19, ii246–ii255.
Zetola, N., Francis, J. S., Nuermberger, E. L. & Bishai, W. R. (2005).
Lancet, 5, 275–286.
Zoll, S., Pa¨tzold, B., Schlag, M., Go¨tz, F., Kalbacher, H. & Stehle, T.
(2010). PLoS Pathog. 6, e1000807.
research papers
198 M. Mihelicˇ et al.  Selection of cleavage sites in NAG-NAM polymers IUCrJ (2017). 4, 185–198
